NCT02696616View on ClinicalTrials.gov

Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

February 14, 2019

Study Completion Date

February 14, 2019

Conditions
Healthy
Interventions
DRUG

BI 655088

DRUG

Placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY